The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.

 
Web www.patentalert.com

< N-substituted heterocyclic sulfonamides

> Echo canceller disabler for modulated data signals

> System and method for improved order entry using market depth

~ 00536